Literature DB >> 28902946

The Association Between Low Grade Systemic Inflammation and Skin Diseases: A Cross-sectional Survey in the Northern Finland Birth Cohort 1966.

Suvi-Päivikki Sinikumpu1, Laura Huilaja, Juha Auvinen, Jari Jokelainen, Katri Puukka, Aimo Ruokonen, Markku Timonen, Kaisa Tasanen.   

Abstract

Low grade inflammation is associated with many noncommunicable diseases. The association between skin diseases in general and systemic inflammation has not previously been studied at the population level. A whole-body investigation on 1,930 adults belonging to Northern Finland Birth Cohort 1966 was performed and high sensitive C-reactive protein (CRP) level was measured as a marker of low grade inflammation in order to determine the association between low grade inflammation and skin diseases in an unselected adult population. After adjustment for confounding factors the following skin disorders were associated with low grade inflammation in multinomial logistic regression analysis: atopic eczema (OR 2.2, 95% CI 1.2-3.9), onychomycosis (OR 2.0, 1.2-3.2) and rosacea (OR 1.7, 1.1-2.5). After additionally adjusting for body mass index and systemic diseases, the risks for atopic eczema (OR 2.4, 1.3-4.6) and onychomycosis (OR 1.9, 1.1-3.1) remained statistically significant. In conclusion, low grade inflammation is present in several skin diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28902946     DOI: 10.2340/00015555-2795

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  8 in total

1.  Association between Rosacea and Cardiovascular Diseases and Related Risk Factors: A Systematic Review and Meta-Analysis.

Authors:  Yanmei Li; Linghong Guo; Dan Hao; Xiaoxue Li; Yujia Wang; Xian Jiang
Journal:  Biomed Res Int       Date:  2020-06-17       Impact factor: 3.411

2.  Allium sativum Extract Chemical Composition, Antioxidant Activity and Antifungal Effect against Meyerozyma guilliermondii and Rhodotorula mucilaginosa Causing Onychomycosis.

Authors:  Marcel Pârvu; Cătălin A Moţ; Alina E Pârvu; Cristina Mircea; Leander Stoeber; Oana Roşca-Casian; Adrian B Ţigu
Journal:  Molecules       Date:  2019-10-31       Impact factor: 4.411

3.  Incidence and remission of aeroallergen sensitization in adults in Northern Finland: 15 years longitudinal study.

Authors:  Anna Karoliina Haarala; Suvi-Päivikki Sinikumpu; Eeva Vaaramo; Jari Jokelainen; Markku Timonen; Juha Auvinen; Juha Pekkanen; Jussi Lampi; Laura Huilaja
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

4.  Cohort Profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966).

Authors:  Tanja Nordström; Jouko Miettunen; Juha Auvinen; Leena Ala-Mursula; Sirkka Keinänen-Kiukaanniemi; Juha Veijola; Marjo-Riitta Järvelin; Sylvain Sebert; Minna Männikkö
Journal:  Int J Epidemiol       Date:  2021-08-29       Impact factor: 7.196

5.  Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study.

Authors:  Daein Choi; Sungjun Choi; Seulggie Choi; Sang Min Park; Hyun-Sun Yoon
Journal:  J Am Heart Assoc       Date:  2021-09-24       Impact factor: 5.501

6.  Skin cancers and their risk factors in older persons: a population-based study.

Authors:  Suvi-Päivikki Sinikumpu; Jari Jokelainen; Sirkka Keinänen-Kiukaanniemi; Laura Huilaja
Journal:  BMC Geriatr       Date:  2022-04-01       Impact factor: 3.921

7.  A Childhood Farm Environment Protects from Allergic Sensitization until Middle Age but Not from New-Onset Sensitization in Adulthood: A 15 Year Longitudinal Study.

Authors:  Anna Karoliina Haarala; Suvi-Päivikki Sinikumpu; Eeva Vaaramo; Jari Jokelainen; Markku Timonen; Juha Auvinen; Juha Pekkanen; Laura Huilaja
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

8.  Cohort profile: COpenhagen ROsacea COhort (COROCO) and COpenhagen MIgraine COhort (COMICO).

Authors:  Nita Katarina Frifelt Wienholtz; Casper Emil Christensen; Jeanette Halskou Haugaard; Ditte Georgina Zhang; Messoud Ashina; Jacob Pontoppidan Thyssen; Alexander Egeberg
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.